At a press conference held here, ACC representative and Associate Professor of Cardiovascular Medicine at Yale University's School of Medicine, Dr Jeptha P Curtis, said collaborations will entail helping the partnering hospital in building a clinical data registry.
The ACC has joined hands with Delhi-based manufacturer of drug-eluting stents and other medical equipment, Translumia Therapeutics, which would in turn help connect the American medical body with hospitals.
"As part of this partnership, the ACC will set up an international centre of excellence at partnering hospitals, which would be a certification of quality," Translumia Therapeurtics' Managing Director, Gurmit Singh Chugh, told reporters.
Alyssa McCormick, Director of International Affairs at the ACC, said the centres would help the hospital by providing a review of the data given by the hospitals on cardiovascular care.
"So, we will bring in our expertise and technical know- how, and analyse the data given by the hospital, and offer them insights, which would help them improve healthcare delivery," she said.
"One aspect that we talk of in cardio-care is 'door-to- baloon' time, which is the time spent from the moment a patient is brought inside the hospital to the time he or she gets cardio-care. And, one of the aspects could be reduction in that 'door-to-baloon' time," he said.
The ACC was set up in 1949 and has about 52,000 members worldwide, McCormick said, adding, "We have about 5,000 members in India.
Disclaimer: No Business Standard Journalist was involved in creation of this content